Welcome to the Joint Graduate Program in Toxicology (JGPT), an interdepartmental program designed to train students and postdoctoral fellows in the discipline of toxicology. The JGPT offers M.S. and Ph.D. degrees and provides the research training for Pharm.D./Ph.D. and M.D./Ph.D. students.

The JGPT was established in 1980 and is administratively housed at the Environmental and Occupational Health Sciences Institute (EOHSI) on the Busch Campus of Rutgers University in Piscataway, NJ. The JGPT curriculum provides broad research training in biochemical, organ system, and mechanistic toxicology with a strong foundation in drug metabolism, pathology, and molecular biology. The Program is administered by the Department of Pharmacology and Toxicology, but draws on mentors come from over 17 different departments on campus to provide multidisciplinary training. Trainees are mentored by over 50 faculty members and academic and industry partners. A NIEHS T32 Training Grant in Environmental Toxicology (T32ES007148) has been the cornerstone of the JGPT for 30 years and supports the tuition and stipends of doctoral students and postdoctoral fellows. All doctoral students receive financial support from training grants, teaching or research fellowships, or from local industry. [read more…]

Applications continue to be accepted on a rolling basis.

Recent News and Accomplishments

Presentation of Latest Research by T32 Trainees to the NIEHS P30 Center Members

Three trainees from the Toxicology and Exposure Science graduate programs presented their latest research during the monthly meeting of P30 ...
Read More

BMS Fellow Raj Shah Shares Latest Research Findings

As part of his career development and mentorship by scientists at Bristol-Myers Squibb, Raj Shah, the 2018-9 JGPT BMS Fellow, ...
Read More

Training in PK Modeling as part of the SOT STEP Award Program

by Dahea "Diana" You This fall, I was fortunate to receive a generous funding from the Society of Toxicology Supplemental ...
Read More

New Approaches in Drug Development

On Nov 30, 2018, Dr. Xiaoyan Chu, Senior Principal Scientist at Merck shared her latest research findings on how endogenous ...
Read More